Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bp Consulting, Inc
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female \>18 years of age scheduled to undergo bilateral cataract surgery
Patients with systemic diseases will be enrolled only if there are no ocular manifestations of their disease (e.g. diabetics with normal retinal exams)
Expected visual outcome of BCVA \> \[greater than or equal to\] 20/30 postoperatively
Ability to provide informed consent, take study medications as directed, and likely to complete all study visits
You may not be if
Known contraindication to any study medication or any of their components
Required use of ocular medications other than the study medications during the study
Significant AMD, epi-retinal membrane, retinal vein occlusion, diabetic macular edema, or any macular disease predisposing them to cystoid macular edema.
Posterior capsule rupture, Vitreous loss during surgery or any other complication that in the surgeon's opinion, could reduce potential for targeted visual outcome
Anticipated need for mechanical iris dilating devices
Clareo Health | Determination of Optimum Duration of Treatment With Bromfenac (Xibrom) Eyedrops Following Cataract Surgery
